机构：[1]Department of Urology, Xiangya Hospital, Central South University, Changsha, China.[2]Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University, Shenyang, China.[3]Department of Endocrinology and Metabolism, Zhongshan Hospital.[4]Fudan Institute for Metabolic Diseases, Fudan University, Shanghai, China.[5]Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou, China.苏州大学附属第二医院[6]Shengli Clinical Medical College of Fujian Medical University and Department of Urology, Fujian Provincial Hospital, Fuzhou, China.[7]Department of Urology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.[8]Department of Urology, The First People's Hospital of Chenzhou, Chenzhou, China.[9]Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, China.[10]Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China.[11]Department of Urology, Shaanxi Provincial People's Hospital, Xi'an, China.[12]Department of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.[13]Department of Urology, Nanchong Central Hospital, The Second Clinical Hospital of North Sichuan Medical College, Szechwan, China.[14]Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China.[15]Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.[16]National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.[17]Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
National Natural Science Foundation of China (No.82170806 to LL and No. 81570711 to XT), the Innovation-Driven Project of Central South University (No.020CX046 to LL), and National Tutorial System training project for youth key talents in Suzhou Health System (Qngg2021007 to YF).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类|2 区医学
小类|2 区内分泌学与代谢
最新[2023]版：
大类|2 区医学
小类|2 区内分泌学与代谢
第一作者：
第一作者机构：[1]Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Urology, Xiangya Hospital, Central South University, Changsha, China.[2]Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University, Shenyang, China.[16]National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.[*1]Department of Urology, Xiangya Hospital, Central South University, 87 Xiangya Road,Changsha, Hunan, 410008, China.[*2]Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning, China.
推荐引用方式(GB/T 7714)：
Li Minghao,He Yazhi,Pang Yingxian,et al.Somatic IDH1 hotspot variants in Chinese patients with pheochromocytomas and paragangliomas[J].The Journal of clinical endocrinology and metabolism.2022,doi:10.1210/clinem/dgac653.
APA：
Li Minghao,He Yazhi,Pang Yingxian,Zhang Jing,Feng Yu...&Jiang Jingjing.(2022).Somatic IDH1 hotspot variants in Chinese patients with pheochromocytomas and paragangliomas.The Journal of clinical endocrinology and metabolism,,
MLA：
Li Minghao,et al."Somatic IDH1 hotspot variants in Chinese patients with pheochromocytomas and paragangliomas".The Journal of clinical endocrinology and metabolism .(2022)
医学